187 related articles for article (PubMed ID: 36420774)
21. [Prospect for chimeric antigen receptor-engineered T cell immunotherapy for solid tumors].
Zhou SY; Shi YK
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):490-492. PubMed ID: 30060355
[TBL] [Abstract][Full Text] [Related]
22. Recent Advances in CAR-Based Solid Tumor Immunotherapy.
Shin MH; Oh E; Kim Y; Nam DH; Jeon SY; Yu JH; Minn D
Cells; 2023 Jun; 12(12):. PubMed ID: 37371075
[TBL] [Abstract][Full Text] [Related]
23. Engineered in vitro tumor models for cell-based immunotherapy.
Ando Y; Mariano C; Shen K
Acta Biomater; 2021 Sep; 132():345-359. PubMed ID: 33857692
[TBL] [Abstract][Full Text] [Related]
24. Understanding the immune landscape and tumor microenvironment of pancreatic cancer to improve immunotherapy.
Torphy RJ; Schulick RD; Zhu Y
Mol Carcinog; 2020 Jul; 59(7):775-782. PubMed ID: 32166821
[TBL] [Abstract][Full Text] [Related]
25. Immunotherapy in hematologic malignancies.
Kansara RR; Speziali C
Curr Oncol; 2020 Apr; 27(Suppl 2):S124-S131. PubMed ID: 32368182
[TBL] [Abstract][Full Text] [Related]
26. The natural killer cell immunotherapy platform: An overview of the landscape of clinical trials in liquid and solid tumors.
Piccinelli S; Romee R; Shapiro RM
Semin Hematol; 2023 Jan; 60(1):42-51. PubMed ID: 37080710
[TBL] [Abstract][Full Text] [Related]
27. Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?
Fry TJ; Lankester AC
Pediatr Clin North Am; 2008 Feb; 55(1):147-67, xi. PubMed ID: 18242319
[TBL] [Abstract][Full Text] [Related]
28. Adoptive Cell Therapy in Treating Pediatric Solid Tumors.
Tesfaye M; Savoldo B
Curr Oncol Rep; 2018 Aug; 20(9):73. PubMed ID: 30069644
[TBL] [Abstract][Full Text] [Related]
29. Folate-targeted immunotherapies: Passive and active strategies for cancer.
Farran B; Pavitra E; Kasa P; Peela S; Rama Raju GS; Nagaraju GP
Cytokine Growth Factor Rev; 2019 Feb; 45():45-52. PubMed ID: 30770191
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapy for brain tumors: understanding early successes and limitations.
Lieberman NAP; Vitanza NA; Crane CA
Expert Rev Neurother; 2018 Mar; 18(3):251-259. PubMed ID: 29322843
[TBL] [Abstract][Full Text] [Related]
31. Immunotherapy in kidney cancer: the past, present, and future.
Hammers H
Curr Opin Urol; 2016 Nov; 26(6):543-7. PubMed ID: 27533501
[TBL] [Abstract][Full Text] [Related]
32. Advances in Chimeric Antigen Receptor T-Cell Therapies for Solid Tumors.
Baybutt TR; Flickinger JC; Caparosa EM; Snook AE
Clin Pharmacol Ther; 2019 Jan; 105(1):71-78. PubMed ID: 30406956
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapy in Pediatric Solid Tumors-A Systematic Review.
Marayati R; Quinn CH; Beierle EA
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31847387
[TBL] [Abstract][Full Text] [Related]
34. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
Plant-Fox AS; O'Halloran K; Goldman S
Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
[TBL] [Abstract][Full Text] [Related]
35. New concepts in tumor antigens: their significance in future immunotherapies for tumors.
Yang F; Yang XF
Cell Mol Immunol; 2005 Oct; 2(5):331-41. PubMed ID: 16368059
[TBL] [Abstract][Full Text] [Related]
36. [New principles in tumor antigens and their significance in future immunotherapies for lymphomas and other malignancies--editorial].
Ke XY; Wang J; Yang XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):419-26. PubMed ID: 16800912
[TBL] [Abstract][Full Text] [Related]
37. Pediatric Cancer Immunotherapy: Opportunities and Challenges.
Wedekind MF; Denton NL; Chen CY; Cripe TP
Paediatr Drugs; 2018 Oct; 20(5):395-408. PubMed ID: 29948928
[TBL] [Abstract][Full Text] [Related]
38. T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments.
Daver N; Alotaibi AS; Bücklein V; Subklewe M
Leukemia; 2021 Jul; 35(7):1843-1863. PubMed ID: 33953290
[TBL] [Abstract][Full Text] [Related]
39. Opportunities and challenges in the immunological therapy of pediatric malignancy: a concise snapshot.
Ceppi F; Beck-Popovic M; Bourquin JP; Renella R
Eur J Pediatr; 2017 Sep; 176(9):1163-1172. PubMed ID: 28803259
[TBL] [Abstract][Full Text] [Related]
40. Immunotherapy in pediatric malignancies: current status and future perspectives.
Capitini CM; Otto M; DeSantes KB; Sondel PM
Future Oncol; 2014; 10(9):1659-78. PubMed ID: 25145434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]